KCA
Search
- Page Path
- HOME > Search
Original Article
- General
- Low-Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity
- Hyunkyung Kim, Seok-Joo Chun, Sojung Sun, Haeun Cho, Tae-Jin Kim, Yoon-Jin Lee, Eui Kyu Chie, Kwangmo Yang, Mi-Sook Kim
- Cancer Res Treat. 2025;57(3):678-692. Published online November 8, 2024
- DOI: https://doi.org/10.4143/crt.2024.807
-
Abstract
PDF
Supplementary Material
PubReader
ePub - Purpose
This study aimed to investigate the potential role of low-dose cyclophosphamide (Cy) as a radiosensitizer by evaluating its impact on the immune response and the abscopal effect of stereotactic ablative radiotherapy through preclinical models.
Materials and Methods
CT26 tumors (immunologically hot) and 4T1 tumors (immunologically cold), grown in immunocompetent BALB/c and immunodeficient BALB/c–nude mice, were irradiated with 20 Gy in two fractions with 5-day spacing followed by intraperitoneal injections of 9 mg/kg Cy every 3 days. Immunological changes in CT26 tumors caused by the treatments were assessed using flow cytometry. Changes in the expression of hypoxia-inducible factor-1α (HIF-1α) in tumors were also assessed. Splenocytes and bone marrow–derived dendritic cells (DCs) were exposed to various concentrations of Cy to assess T cell proliferation and DC differentiation.
Results
The combination of Cy with radiotherapy (RT+Cy) significantly suppressed tumor growth compared to RT alone in immunocompetent mice, while that effect was not observed in immunodeficient mice. Additionally, RT+Cy effectively induced abscopal effects in hot and cold tumors, with increased CD8+ T cells in blood and tumors. Significantly higher expression levels of granzyme B, interferon γ, and tumor necrosis factor α were observed in RT+Cy group compared to the RT alone group. In vitro data indicated that low-dose Cy promotes DC differentiation. Low-dose Cy suppressed the radiation-induced upregulation of HIF-1α in the tumors.
Conclusion
Low-dose Cy enhances tumoricidal effects of 5-day spacing high-dose RT by increasing antitumor immune responses. -
Citations
Citations to this article as recorded by
- Regulatory T cells in cancer: from immunosuppression to therapeutic targeting
Paola Basurto-Olvera, Hector Serrano, Carmen Maldonado-Bernal
Frontiers in Immunology.2025;[Epub] CrossRef - Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patients
Jessica Oliver, Hannah Reed, Lorenzo Capitani, Ashley Poon-King, Ashleigh Young, Stefan Milutinovic, Mateusz Kuczynski, Owen Nicholas, Thomas Rackley, Catherine Pembroke, Andrew Godkin, Awen M. Gallimore
Cancer Immunology, Immunotherapy.2025;[Epub] CrossRef
- Regulatory T cells in cancer: from immunosuppression to therapeutic targeting
- 3,649 View
- 133 Download
- 2 Web of Science
- 2 Crossref
First
Prev
